Abstract
In March 2023, over 800 researchers, clinicians, patients, survivors,
and advocates from the pediatric oncology community met to discuss the
progress, plans, and future priorities of the National Cancer
Institute’s Childhood Cancer Data Initiative. We present here the status
of the initiative’s efforts in building its data ecosystem to provide
access to childhood cancer data; updates on the Molecular
Characterization Initiative; plans for implementing a Coordinated
National Initiative for Rare Cancers in Children and Young Adults; and
efforts to establish a framework for computable consent.